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Flow Cytometry is an analytical technology to simultaneously measure multiple markers per single cell. 
Ten thousands to millions of single cells can be measured per sample and each sample may contain 
a different number of cells. All samples may be bundled together, leading to a ‘multi-set’ structure. 
Many multivariate methods have been developed for Flow Cytometry data but none of them considers 
this structure in their quantitative handling of the data. The standard pre-processing used by existing 
multivariate methods provides models mainly influenced by the samples with more cells, while such 
a model should provide a balanced view of the biomedical information within all measurements. We 
propose an alternative ‘multi-set’ preprocessing that corrects for the difference in number of cells 
measured, balancing the relative importance of each multi-cell sample in the data while using all 
data collected from these expensive analyses. Moreover, one case example shows how multi-set pre-
processing may benefit removal of undesired measurement-to-measurement variability and another 
where class-based multi-set pre-processing enhances the studied response upon comparison to the 
control reference samples. Our results show that adjusting data analysis algorithms to consider this 
multi-set structure may greatly benefit immunological insight and classification performance of Flow 
Cytometry data.
Multicolor Flow Cytometry (MFC) is a powerful technique for quantitative detection of cellular marker expres-
sion at the single-cell level. MFC technology has become routine for biological studies and clinical diagnoses. In 
immunology, the main applications of MFC span the identification and quantification of cell subpopulations, 
monitoring of disease and its treatment and studying dynamic cellular processes such as cell differentiation1–3. 
Applications involve automated comparison of increasing numbers of samples, in which large numbers of cells are 
typically collected in every sample. Furthermore, many contemporary experiments quantitatively compare a ‘case’ 
(or responder) groups of samples against a ‘control’ (or healthy) sample group, in which expressions of identical 
cellular markers may be measured on the cells within all samples.
Figure 1 shows the possible arrangements of the MFC data by considering three different levels. Single matri-
ces, which hold the cell set measured per sample (level 1); comprehensive analysis of different samples require 
that the same cellular markers are measured across all samples. Single matrices may then be concatenated column 
(or variable)-wise leading to a multi-set structure where each set contains the cells of one sample (level 2) as com-
monly described in chemometrics4,5. Each sample might be either a control or a responder and the information of 
the respective group is displayed in the level 3 of the multi-set structure. In some cases, samples are paired, which 
means that the same person is followed over time and analysed before and during an immune response. In this 
case the index i is not unique (3a); while for unpaired samples, each set is indicated by a different i (3b).
Several multivariate data analysis methods have been developed to quantitatively explore the cell composition 
of MFC samples6. To our knowledge, none of these methods quantitatively accounts for the multi-set structure 
of MFC data either in the pre-processing or in the analysis step. This may lead to a suboptimal overview and 
interpretability of the cell variability across all samples, instead reflecting non-biologically relevant inter-group 
or inter-sample variability. The problem especially occurs when different number of cells are measured between 
samples and/or baseline shifts are present between the samples due to e.g. technical variation.
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Multivariate analysis methods such as Citrus7 and FlowSOM8 concatenate the MFC sample measurements in 
a single big matrix, without retaining the information about the different sets, prior to the analysis. Both methods 
then comprise mean-center and scaling based on such concatenated samples. If the various samples strongly dif-
fer in the number of cells measured, the calculated mean and standard deviation would be affected and, as result, 
the model will mainly describe the cellular marker variability of the samples with the most cells. Instead, a model 
where each sample equally contributes to, is desirable to avoid misleading results. In other algorithms, such as 
SPADE9 and viSNE10, problems related to difference in number of cells measured may be avoided by downsam-
pling the data to a fixed and equal number of cells per sample. Downsampling causes loss of valuable data, which 
may result in an unreliable model estimation and may result in losing important cells that might be essential in 
several high-impact application of MFC, e.g. minimal residual disease detection.
The multi-set-structure has already been an integral part of the methods DAMACY11 and ECLIPSE12. Both 
DAMACY and ECLIPSE consider the multi-set structure during the pre-processing steps and when building 
the models to compare samples. However, until now we have not yet presented a detailed study to show how the 
multi-set pre-processing is in need when analysing MFC data, to avoid suboptimal immunological interpretation 
or even misinterpretation of the results.
In this paper we comprehensively review the multi-set structure and present the multiset pre-processing in 
order to create awareness for additional pre-processing options and how these options may be beneficial for the 
analysis and interpretation. The multi-set pre-processing corrects for the difference in number of cells measured 
per sample, by averaging the mean and the (square root) of the variance between samples and thus providing a 
more reliable representation of variability in the original marker expressions within the separate samples. We show 
how default pre-processing may be harmful by simulating a sample with fifty times more cells than other samples, 
by experimental quantification with an LPS benchmark study and with an obese versus lean study. The LPS study 
is based on neutrophils which has a high measurement-to-measurement variability and this unwanted technical 
variation affects all multivariate methods tested, namely PCA, SOM, t-SNE and Citrus. For this reason we show 
and advise to pre-process the data per sample, to correct for unwanted technical measurement-to-measurement 
variability and to highlight the studied underlying immunological effect. Pre-processing based on all cells of all 
control samples may enhance the deviation of immune response-specific marker variability from a control refer-
ence marker expression and lead to a better discrimination and diagnosis accuracy, as we show with DAMACY 
in an obese and lean study. Also algorithms such as viSNE and SPADE, which are distance based methods and 
do not explicitly use the mean, may benefit from the multi-set pre-processing. It may alter the relative differences 
between cells in different samples, thereby removing unwanted variation and essentially improving the informa-
tion content of the models.
Figure 1. (1) Single data matrices representing measurement per sample, (2) When same variables are 
measured data can be arranged in a multi-set structure by linking the single matrices column-wise, (3a) 
Control/Responder differentiation of the multi-set structure, with paired data, (3b) Control/Responder 
differentiation of the multi-set structure, with unpaired data.
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Methods
Peripheral blood was extracted from subjects in both the LPS challenge study and obese versus lean study, all 
of whom gave their written informed consent before participating. All data were obtained using standardised 
protocols. The LPS challenge study and sample collection were approved by the medical ethics committee of 
Radboud University Medical Center (Radboudumc) Nijmegen, The Netherlands. The study protocol of the obese 
versus lean study was approved by the Medical Ethical Committee Jessa hospital, Hasselt, and Hasselt University, 
Belgium. Both studies were performed in accordance with the Declaration of Helsinki (Forteleza, 2013).
LPS study data. MFC data of the “Lipopolysaccharide study” were part of an endotoxin trial (NCT01374711; 
www.clinicaltrials.gov), in which male healthy donors were challenged with intravenous administration of 
Lipopolysaccharide (LPS). The LPS dataset comprises gated neutrophils from 16 samples: 8 ‘control’ (or refer-
ence) samples who did not receive LPS, and 8 different ‘response’ samples who were administered with LPS. For 
the responders, whole blood was collected 180 minutes post LPS administration. Seven surface markers were 
measured on the neutrophils in samples of both classes: CD62L, CD11b, CD11c, CD64, CD32, CD69, and CD16. 
The samples size range between 6 thousand to 40 thousands cells. Further details regarding the Flow Cytometry 
experiments that generated the data can be found in a previous publication13.
Obese data. The obese data comprises 29 samples: 13 lean samples with Body mass index (BMI) in the range 
between 20.83 and 25.62 and 16 obese samples with BMI between 30.47 and 49.2714. The following markers were 
measured: CXRCR1, CD14, CD56, CD11b, CD11c, CD16, HLA-DR, CD3/CD19/CD66b. The data was gated 
on innate cells by removing all cell positive for markers CD3, CD19, CD66b. The samples have 2 thousand to 24 
thousand cells left after gating.
Data pre-processing. Data pre-processing is a crucial aspect of multivariate data analysis15 to remove var-
iability in the data that is unrelated to the problem under study, while retaining the experimentally relevant 
information. In Flow Cytometry, such irrelevant variability might result from instrumental artefacts due to mis-
alignment of the laser source, baseline drift, laser power variability, or uninformative noise coming from low 
intensity signals. Time delays between sample collection and measurements can also bring variability that is not 
related to the problem under study. Especially granulocytes should either be measured fresh and as fast as possi-
ble, or measured after using advanced freezing techniques to minimize such nonspecific activation16,17.


















 of size ∑ N JxI i1 g , where Nig is the number of cells of the 
igth sample, with g = 0 used for the control group and g ≥ 1 for responder groups and J corresponds to the markers 
measured, 1…j…J. The first step of the pre-processing consists of transforming X with log (Eq. 1a) or hyperbolic 
inverse sine (arcsinh) function (Eq. 1b)18.























These transformations perform a non-linear conversion of the data and they are generally applied to correct 
for heteroscedasticity and to change skewed distributions into more symmetric, Gaussian distributed peaks. A 
log transformation may be still used on datasets exported with only positive data values, arcsinh transformation 
has been introduced to accommodate for the negative values in MFC data that may result from the background 
subtractions performed by newer digital MFC technology, or by compensation19. We used arcsinh transformation 
with a default cofactor c value of 150 and used visual inspection of the data to preclude the emergence of any ‘split 
peaks’ upon transformation20.
Multi-set centering and scaling. Arcsinh and log transformation can be considered as a ‘pseudo scaling’ 
transformation that ameliorates magnitude differences in the fluorescence emissions per fluorophore between 
different markers. However, full removal of such differences requires variable scaling and mean centering after 
transformation21. Mean (or median) centering subtracts the column mean (or median) from every element in 
the column. Median centering is required when the number of cells measured is very low. This removes marker 
expression (or offsets) consistently present across all the cells and creates a common point of reference to quantify 
variability in cellular marker expression between the cells. Centering is typically applied in combination with scal-
ing, which consists in dividing each variable by a scaling factor. Scaling equalizes the variability of each cellular 
marker across the cells. This allows the variability in every surface marker to contribute equally to a multivariate 
model of the data, regardless of the intensity of the used fluorophore or the absolute variability in abundance of 
every surface marker.
In the pre-processing as applied in Citrus7 and flowSOM8 analyses, all the data files are bundle together in a 
big data matrix and, after transformation, centering is performed according to Equation 2:
=
N
m X1 1 (2a)N
T
log
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= −X X 1 m (2b)Nm log
T
where m is the mean of the arcsinh (or log-) transformed cellular marker expression calculated across all the sam-
ples included in the matrix Xlog; N is the number of total cells measured; 1 is a column vector of ones with length 
N. The mean-centered matrix Xm is then scaled according to Equation 3:
= vars X( ) (3a)m
T
=S diag s( ) (3b)
T
=X X S (3c)msc
T
with S diagonal matrix holding the standard deviation sT; Xsc the resulting auto-scaled matrix.
This ‘standard’ pre-processing ignores the multi-set structure (Fig. 1) of multi-cells Flow Cytometry data 
which means that the information of cells belonging to a specific sample or group is lost.
Our ‘multi-set’ pre-processing specifically accommodates the multi-set structure of Flow Cytometry data and 
tackles various sub-aspects: cells measured may belong to different samples, where these can be drawn from 
different experimental cohorts (such as control and responder) and different numbers of cells can be measured 
per sample. Several strategies for centering and scaling21 are therefore available which may lead to different views 
and information: to centre/scale using the mean/standard deviation calculated on all the samples, on the control 
samples or per sample.
The different pre-processing strategies were tested on simulated data which consisted of normal distributions, 
representing different cell populations (Online Supplementary Material I).
In Fig. 2 the effect of three different types of centering on this dataset is displayed, without any scaling: center-
ing over the whole dataset, based on group-level, and per sample.
Centering over the whole dataset employs the data from both the responder and control groups. This center-
ing operation requires a correction for the possibly different number of cells measured per sample, to avoid the 
sample with most cells dominating the calculated mean. Thus, creating a common reference point between the 
samples and not in the sample with the most cells, see for more infomration supplementary Figure S3, S5B and 

































= −X X m1 (4c)Nm log
T
ig
Figure 2. 2D scatter plot of the simulated data after applying different types of centering on both control (red) 
and responder (blue) populations. Left (A) data are centered using the mean calculated on the whole dataset and 
correcting for differences in # cells measured per sample; Center (B) data are centered using the mean estimated 
for the control samples and correcting for differences in # cells measured per control; Right (C) data are mean 
center per sample.
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Here, the average marker expression Xm based on all the samples m is calculated by dividing the sample-specific 
mean mi g, estimated per each sample i of group g, over the total number of samples Ig. Centering over the whole 
dataset (Eq. 4c) translates the means of both groups around the axis coordinate origin (mcontrol = 0,−2; mresponse = 
0,2), as displayed in Fig. 2a.
Centering can be performed based on group (control)-level, which means the control group is used as point 















= −X X 1 m (5b)Nm log 0
T
ig0
Also in this case, a correction for different numbers of cells per sample is performed by using the mean of each 
i0–th control sample mi0 to calculate the weighted control class mean m0, where I0 represents the number of con-
trol samples. The resulting Xm0, of size N Jxi0 , represents the multi-set matrix centered using the class mean of the 
log-transformed surface marker intensities of the control group. Centring based on the control samples (Eq. 5b) 
will remove the shift of the control cells of which variability is used as reference. This emphasizes the deviation of 
responder cell variability (mresponse = 0,2) from the control reference (mcontrol = 0,0), as shown in Fig. 2b.












= −X X 1 m (6b)i N im log,
T
ig g ig g
where mi g is the mean calculated for the cellular markers measurements of the ig–th sample, = …i 1 , , Ig g G, the 
matrix X ilog, g of size N Jxi g ; Nig corresponds to the number of cells of the ig–th sample; 1 is a column vector of ones 
with length Nig. Centering per sample (or per individual) (Eq. 6b) removes the shift per sample in both groups 
(mcontrol = mresponse = 0,0), as shown in Fig. 2c. This strategy may be used to correct for technical sample-specific 
offsets due to e.g. changes and/or misalignment of laser intensity, sample handling etc. that are unrelated to the 
biomedical information within a MFC dataset.
Additionally to centering, scaling is performed. As for centering, the same alternatives are available also for the 
scaling step. Below, we discuss and show the formulas of the different scaling options performed on the sample 
mean centered data matrix Xm ig
 (Eq. 4). Each formula can be easily adapted to the other types of centering. 
Similar conclusions about the effect of scaling can be drawn and they are summarized in Fig. 3.























=S diag s( ) (7b)
T
= −X X S (7c)sc m
1
i
where S is a diagonal matrix of size J × J containing the standard deviation (or median absolute deviation) of each 
surface marker sT, calculated on all cells of all samples. Median absolute deviation is required when the number 
of cells measured is very low. Scaling based on the complete data will keep the same difference in shape between 
control (scontrol = 0.34, 1.37) and responder (sresponse = 1.37, 0.34) population, but the variables are now equally 
important (s = 1,1).
Scaling based on the control group is given in Eq. 8:
=













=S diag s( ) (8b)
T
0 0
= −X X S (8c)sc m 0
1
i
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With S0 of dimensions (J × J) with the diagonal element containing the standard deviation sT0  of each surface 
marker based on all cells of control samples. Scaling based on the control group will remove the shape of the 
control (scontrol = 1, 1) and emphasize the shape of the challenged population (sresponse = 4, 0.25).
Scaling per sample is calculated as follows:
= ( )vars X (9a)iT mg i
= ( )S diag s (9b)i iTg g
= −X X S (9c)imsc
1
i g
where Si g is diagonal matrix of size J × J holding the standard deviation of the mean-centered surface markers of 
the ig–th sample. Scaling per sample makes cell population of both groups homogenous (scontrol = sresponse= 1, 1).
The plots in Fig. 3 show that, the method of pre-processing may greatly determine the pre-processed data 
structure. Centering and scaling based on the control class will enhance the deviations of the responder samples 
from the cell variability observed in the control samples. Alternatively, sample centering and scaling might be a 
preferable option when measurements were influenced by differences in the (technical or practical) experimental 
procedure per sample. However, it should be noted that the last option has a considerable disadvantage. When all 
cells of one response sample show up or downregulation of one or multiple markers compared to the cells of the 
control samples, this information will be lost due to sample centering and scaling. However, when the technical 
differences are bigger than the biological differences and thus the between sample variability is higher than the 
between group variability, it may be the only solution as the shape and number of cells may still be important, see 
supplementary Scheme S1.
Correcting the number of cells per sample for principal component analysis. Principal 
Component Analysis (PCA) is a widely used method to visualize multidimensional data, including Flow 
Cytometry data, while retaining most of the variability expressed in the originally measured variables22,23. A 
multi-set extension of PCA exists to accommodate multi-set structure present in the data and it is known as 
Simultaneous Component Analysis (SCA)24. When applying the SCA decomposition, the pre-processed matrix 
Figure 3. 2D scatter plot of the simulated data pre-processed with different pre-processing options. A ‘control’ 
population (red rounds) and a ‘responder’ population (blue triangles) are present. The columns display the 
scaling options (from left to right): scaling over the whole dataset, scaling based on the control group and 
scaling per sample. The rows correspond to the centring options (from top to bottom): centering over the whole 
dataset, centering based on the control group and centring per sample.
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Xsc is normalized such that each sample contributes with the same amount of information. The normalization is 
done by blockscaling25, which consists of dividing each sample by the square root of the corresponding number 

































SCA then decomposed the resulting matrix as follows:
= +⁎ ⁎ ⁎X T P E (11a)
T
sc
= ⁎T X P (11b)sc





 contains the SCA scores, k = 1,…, K indicates the dimensionality of the new 
low-dimensional space, P* of size K × J containing the loadings and E being the residuals. The loadings represent 
the contribution of each cellular marker in building the low dimensional space and in describing the cell variabil-
ity contained in the scores matrix. Blockscaling is essential to estimate loadings which are not highly influenced 
by the cellular maker variability of the samples with the most samples. The relations between cell variability and 
the related expression of markers in the SCA space may be combined in a single biplot26.
Results
The effect of measurement-to-measurement variability and dedicated pre-processing on 
the interpretation of viSNE, SOM and Citrus models of real life data: the Lipopolysaccharide 
study. The Lipopolysaccharide (LPS) challenge study entails intravenous administration of systemic endo-
toxin to eight volunteers. This experiment is used to mimic acute inflammation in humans which is most 
prominent 180 minutes after LPS administration13,27. Previous publications have shown that upon acute inflam-
mation, two neutrophil subsets arise in the peripheral blood, which differentially express FcγRIII (CD16) and 
L-selectin (CD62L). Neutrophils under homeostasis express both CD16 and CD62L, while both arising sub-
sets are CD16+CD62L- and CD16-CD62L+, with different morphological and functional features13. The chal-
lenge aimed to characterize the expression of activation markers on the neutrophil subsets released in peripheral 
blood during the LPS-induced response, compared to a homeostatic reference present in the control group. 
Considerable shifts of the fluorescence signals are present between the samples in both groups for nearly all 
markers, as shown in Figure S8 in the Supplementary Material II. Changes in the absolute position of the same 
cell population across the samples might result from both (not-relevant) biological and technical variation28. 
Various studies have shown how different sample treatments may affect marker expression on neutrophils16,17. 
Additionally, time delay between sample collections, reagent staining and actual measurements may vary across 
the samples and this introduces an uncontrolled between-sample variation which can hinder an accurate data 
analysis and influence interpretation of the findings when the data is not accurately corrected for this.
After log-transformation, we pre-processed the LPS data with both standard pre-processing, according to 
Equations 1–2, and multiset pre-processing, consisting of mean-centering per individual and scaling over the 
control group (Equations 6–8). This multi-set pre-processing accounts for difference in terms of numbers of cells 
measured per individual sample and may correct for shifts caused by between-sample variability.
The effect of the different pre-processing strategies on the LPS data was investigated by applying self-organizing 
(SOM) map using the toolbox implemented in Matlab29 with same parameter settings as in flowSOM8: grid size 
of 10 ×10, Euclidean distance to find nearest neighbor, and training length of 10 epochs. The resulting clustering 
performed by SOM trained on the standard pre-processed and multi-set preprocessed data can be visualized in 
the Supplementary Figure 9A-B, respectively. Nodes are displayed with pie chart representing the average inten-
sities of the markers for all the cells assigned to the specific node. Based on this representation, we can observed 
that both trees seem to be dominated by the majority of normal mature neutrophils having CD16+CD62L+ 
expression. Previous work has shown how the vast number of normal-like cells presents in the responder indi-
viduals can hamper the identification of response-specific cell subsets12. However, when coloring the pie chart 
according to the number of cells from each sample in the nodes, a major difference is revealed between the clus-
tering results for the diversely pre-processed data (Fig. 4A-B, respectively). A sample-specific clustering is present 
in the SOM tree obtained for the standard pre-processed data (Fig. 4A). In fact, a considerable number of nodes 
consists of cells from mainly the same sample or only a few samples. This indicates that SOM algorithm is influ-
enced by between-sample variability which dominates the model at the expenses of the subtler variability related 
to the homogenous LPS-induced response.
Such between-samples variability is removed by the multi-set pre-processing and as a result the cells from the 
16 samples are distributed throughout the tree (Fig. 4B). The multi-set pre-processing thus leads to a cell cluster-
ing mostly based on marker expression variability within the samples, rather than between samples.
An insight at single-cell resolution level was obtained by viSNE10 analysis. The analysis was done using the 
Matlab GUI cyt, downloaded from the website https://www.c2b2.columbia.edu/danapeerlab. For each sample 
we randomly selected a subset of 2000 cells, so that the total number of cells analyzed was 32.000. The results 
of viSNE analysis are shown in the Supplementary Material II (Figure S10). Likewise for the SOM representa-
tion, when performing viSNE on the standard pre-processed data, cells of the same sample are mostly grouped 
together (Figure S10A), suggesting that the clusters found by the algorithm are sample specific. When the viSNE 
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map is colored according to the control/response group (Figure S10B), cells of the control and response sam-
ples overlap considerably. The upper left region and the middle low area appear to be distinctive regions for 
the responder. However, not all the responder samples show cells in those regions. Single marker expression 
profiles are visualized in Figure S11. Premature (banded nucleus) neutrophils can be detected as having a typical 
CD16-CD62L+ expression. We therefore gated the region corresponding to this phenotype in the viSNE map and 
extracted the cells within the gate. Cells contained in the gate, and thus associated to the premature phenotype, 
are mainly represented by cells from a single sample (Patient #5), as shown in the bar plot Figure S12 of the Online 
Supplementary Material II.
Contrary to the standard pre-processed data, the viSNE map obtained for the multi-set preprocessed data, 
colored per sample, shows how the cells are distributed across the map and no sample-specific clusters are present 
(Figure S14A). As expected, considerable overlap is present between cells from the responder (red, Figure S14B) 
and control groups (blue, Figure S14B).The map is then colored according to the seven marker expression pro-
files. LPS-specific cells CD62L-CD16+CD11b+ are well distinct in the upper left part of the map (Figure S15). 
Pre-mature neutrophils CD16-CD62L+ were also identified. As done for the previous viSNE analysis we gated 
this region and we observed that cells within the gate are from multiple responders as shown in the bar plot 
Figure S16. The viSNE analysis applied on the multi-set pre-processed data thus models the LPS-induced 
response across all the responder individuals and no sample-to-sample variation seems to be dominant. Thus 
multiset pre-processing better reflects the original data where all responders showed a broader CD16 distribution 
compared to controls, see Figure S8.
In order to experimental quantify whether the pre-processing could affect the results of a discrimination 
model between the control and responder groups, we performed a Citrus7 analysis on the Cytobank platform 
(https://www.cytobank.org/). The model identified as optimal for the analysis on the standard pre-processed 
data (cv.min in Fig S16A, Supplementary Material II) provided the highest accuracy achievable, corresponding 
to 25% of misclassified samples. When Citrus analysis was trained on the multi-set pre-processed data, a perfect 
classification was obtained as shown in the Supplementary Material II (Fig S17A). The phenotypes of the cell clus-
ters associated with the four features, corresponding to a null cross-validation error rate, are shown in Fig S17B. 
The first three clusters are more abundant in the responder group and they may be associated to premature and 
mature neutrophils. The last cluster found more present in the control group compared to the responder group 
may be assigned to normal mature neutrophils having CD16+CD62L+ expression.
Experimental quantification of correcting for sample size and multiset pre-processing using 
Discriminant Analysis of Multi-Aspect Cytometry (DAMACY). In this section we used Discriminant 
Analysis of Multi-Aspect Cytometry (DAMACY)11 to explore the different pre-processing options mentioned 
in the method section. DAMACY11 first describes the cellular variability in N-dimensional histograms based on 
Simultaneous Component Analysis (SCA) of the pre-processed data using the multi-set structure. Subsequently 
it uses Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA)30 on the histograms to create a regres-
sion map. The regression map shows which cell (sub)populations are more or less present in a clinical phenotype 
compared to control samples. The whole algorithm, including the pre-processing step, was validated using leave 
one out validation in the LPS results and seven-fold cross-validation with fifty iteration in the obese dataset. 
Both datasets were permutated 1000 times for permutation testing. This leads to well statically validated pre-
diction accuracies that may be compared with each other and compared to maximum accuracy achieved on the 
Figure 4. SOM analysis results. Nodes of the SOM trees are colored according to the number of cells belonging 
to the different individuals. Panel (A) SOM tree results obtained for the standard pre-processed LPS dataset, 
consisting of centering and scaling by using mean and standard deviation calculated over the all the samples; 
Panel (B) SOM tree results obtained for the multi-set pre-processed LPS dataset, consisting of centering per 
individual and scaling over the control individuals.
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permutated data to see if the models are significant and not by chance have a high accuracy. Only DAMACY was 
used, because the multi-set preprocessing options are not yet incorporated in other methods and thus unable to 
correctly validate the results. The only multiset pre-processing option possible in other methods such as Citrus 
(previous paragraph) is individual centering and scaling since those are not affected by the cross validation.
LPS results. In addition to providing enhanced insight, multi-set pre-processing may also benefit the dis-
criminative power between control and LPS responders. Supplementary table 1 shows the prediction perfor-
mance of different pre-processing strategies using DAMACY. Standard concatenating the data and subsequently 
autoscaling leads to a prediction accuracy of 75% and a p-value of <720/1000. Perfect prediction (p-value 
<4/1000) is acquired when multi-set individual centering combined with scaling over the entire set and cor-
recting for the number of cells per sample or scaling per individual sample. Also the number of orthogonal 
latent variables (OLV) drops, probably because the pre-processing already removed a large part of the orthogonal 
information. Centering based on the whole set in combination with scaling per individual sample leads to an 
unpredictable model. The data is characterized by shifts in mean due to technical variation of the samples, but 
also has a biological increase in variability in most markers due to the LPS induced effect. Scaling per individual 
without centering per individual only removes biological but not the technical variability, which therefore lowers 
prediction accuracy.
Obesity versus lean data. Different pre-processing strategies were tested with DAMACY on the obese vs 
lean dataset, using seven-fold cross validation with 50 repetitions. The prediction performance is summarized in 
supplementary table 2. Standard pre-processing of the data leads already to a high prediction accuracy of 76.6% 
(p-value < 28/1000), mainly because the obese samples are well predicted (high sensitivity). The obese samples 
have more cells measured compared to the lean individuals and are therefore more important in the model and 
also better predicted. Centering and scaling based on the whole set considering the number of cells per sample 
(dark blue) creates a model with worse accuracy but with increased specificity. Centering based on the con-
trols (lean individuals) enhanced the difference between obese and lean and led to a slightly better model than 
standard pre-processing. Individual centering of the data removes the shift in marker expression found in obese 
individuals and results in bad predicting models, while individual scaling in this data improved the prediction 
accuracy.
Figure 5 shows the DAMACY model based on optimal pre-processing, while DAMACY model based on 
standard pre-processing and worst pre-processing are displayed in Figure S19 and Figure S20 of the Online 
Supplementary Material III, respectively. Cells identified as classical monocytes are in direction of CD14 and 
HLA-DR and they show a split in upper blue highlighted and lower red highlighted area which corresponds 
to increasing CD11b, CD11c and CX3CR1 expression in cells more present in obese individuals. The same 
increase is also observed in NK cells in direction of CD16 and CD56. Moreover, a trend in blue highlighted areas 
corresponding to more cells in obese individuals from CD14 towards CD16 is observed, which corresponds 
to transition of classical, intermediate and non-classical monocytes (CD14−CD16+). The same information is 
more difficult to extract from the model based on standard pre-processing, because the trend is more skewed, 
see Figure S19 and completely absent in the model based on worst pre-processing, see Figure S20. Therefore, 
multi-set pre-processing is beneficial for interpretation, even when it does not specifically enhance diagnostic 
potential. However a screening through all the possible options should be done in order to obtain the optimal 
results15.
Figure 5. DAMACY model of obese versus lean data with optimal centering based on control and scaling per 
individual. The left panel shows the average prediction score of the OPLS-DA model of controls as red rounds 
and asthma individuals as blue crosses. The right panel shows negative weights as red and positive weights as 
blue. The loadings of the Base model are plotted on top as black vectors and indicate how each surface marker 
contributes to the cell variability in a specific direction within the model.
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Discussion
The integration of the multi-set structure in the pre-processing and multivariate analysis steps of MFC data is 
essential to overcome the influences of non-informative aspects in the data. Here we showed that our multi-set 
pre-processing may be essential to extract the full biomedical information from MFC data consisting of samples 
(sets) which may belong to different groups (e.g. case vs control) and may be characterized by different number of 
cells measured. Based on classification accuracy, biomedical insight or both.
Difference number of cells measured per set. If the difference in number of cells measured between 
samples is not corrected, this may bias the analysis results and thus lead to a misleading interpretation of the 
findings. This happens because when MFC data are pre-processed (by mean centering and scaling), as stand-
ardly done in most analysis methods such as Citrus and flowSOM, the calculated mean shifts towards the sam-
ple(s) with most cells (see simulated data results). The effect of the shift in multivariate analysis is shown by 
Simultaneous Component Analysis (SCA), which was chosen as it offers a representation of cells population 
together with marker (co)-expression in a single plot. Blockscaling (Eq. 11) is an integral part of the SCA analysis 
when estimating the loadings. The SCA scores are then calculated by multiplying the pre-processed data with 
such corrected loadings. We showed that only when blockscaling is combined with multi-set pre-processing, 
the resulting SCA model offers the best representation of the original marker expression when the number of 
cells in one of the samples was increased (Figure S7). In other simulated data (Figure S5) with less correlation 
structure because only three variables were measured, blockscaling had a negligible influence but the correction 
provided by the multi-set pre-processing improved the interpretation of the results. The correction provided 
by our multi-set pre-processing can be a more optimal solution to down-sample the sets that uses all collected 
data, as done for SPADE and (optionally) in viSNE, to make each sample equally contribute to the built model. 
Additionally, it will be crucial when low abundant cell populations are relevant, as their detection could be ham-
pered as the mean shifts greatly to the more abundant populations.
Measurement-to-measurement variability. Finding biological variability in the samples which is rele-
vant to the studied response/disease is one of major challenge in MFC data analysis. Our multi-set pre-processing 
strategy enables to systematically remove variability unrelated to the studied problem while retaining the inform-
ative biological information. Non-relevant biological or technical variation could provoke shifts of fluorescence 
signals of the same cell population among the samples, as in the case of the LPS dataset. When applying standard 
pre-processing to the LPS data, this variability is not removed and remained quite dominant in the multivariate 
analyses performed. The viSNE and SOM models thus intrinsically described mainly this unwanted variability 
leading to trivial conclusions. In fact, the obtained results enabled us to identify putative phenotypically different 
cells subsets which are not realistically representing the homogenous immune response across all the samples. We 
showed how this sample-to-sample variability might also lead to a suboptimal discrimination accuracy in Citrus 
and DAMACY analysis. By using multi-set pre-processing was beneficial for viSNE and SOM analyses of which 
results were better representing the phenotypical variation present in the data. It also helped in outperforming the 
predictive ability of the Citrus and DAMACY discriminant models.
The effect of pre-processing investigated using Control vs case studies / data. Diagnostic abil-
ity is another challenge for which MFC data analysis methods should be used. The multi-set structure allows 
for pre-processing based on only the control samples to enhance the differences between case/responder and 
control, which may improve the discrimination and diagnostic ability. In the case of obese versus lean data 
standard pre-processing already performed very well with 76.6% accuracy, when compared to 76.8% accuracy 
in the optimal model with control centering and individual scaling. However, the optimal model enhances the 
response-specific variability in the case samples, and is therefore better able to describe the relationship between 
the markers measured. This will allow better and more robust interpretation of the data, as shown in the compar-
ison between Fig. 5 and Fig S19 and S20 The high accuracy in standard pre-processing is mainly caused by the 
high sensitivity, probably because the obese samples had more cells measured and were thus better modeled com-
pared to the control individuals. Also, pre-processing choices could be made that are detrimental to the predictive 
power, as the worst model based on individual centering and scaling on the whole dataset lead to a prediction 
accuracy of only 61.4%, which is a decrease of around 15% compared to standard pre-processing. A systematic 
exploration of all options for multi-set and case-control pre-processing using cross validation and permutation 
testing is essential to obtain an optimally predictive model15. However, an external test set is still required to test 
the optimal predictive model or should be at least compared with literature and visual inspection is needed for 
quality control and to interpret the model6,31. The current pre-processing setup entails only a limited number of 
possible permutations, but it needs to be integrated with the other pre-processing steps for MFC, such as trans-
formation and compensation.
conclusion
Nowadays most of the widespread applications of MFC involve the measurements of cells from several patients. 
The same markers are measured across all the patients and this enables the arrangement of MFC data in a 
multi-set structure. Here we presented how the integration of multi-set structure in the pre-processing and analy-
sis of MFC data led to better interpretation of the analysis methods the results and corrected for challenges occur-
ring in MFC. In fact, the multi-set pre-processing proposed corrects for difference in number of cells measured 
across all the patients. This difference should be always taken in consideration because it may be detrimental for 
the interpretation of the findings of the analysis method used, as demonstrated with the simulations proposed.
In addition, the versatility of the pre-processing algorithm allows several different pre-processing strate-
gies. These include solutions to remove unwanted non-biological/technical variation between the samples and 
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strategies to best accommodate the study research questions, e.g. discrimination between control and diseased/
case group. Control based centering and/or scaling may enhance the effect of the diseased/case group in the 
model. Individual centering and or scaling may be useful when the model shows an unequal distribution of indi-
vidual samples, e.g. cells from an individual are only in one part of the t-SNE map or flowSOM tree meaning that 
the model only describes individual variation instead of between group variation.
The multi-set pre-processing (already present in DAMACY and ECLIPSE algorithms) may be implemented in 
any multivariate data analysis methods. This may enable outperforming of prediction accuracy and lead to more 
robust results.
Data availability
The data can be downloaded from the website: https://www.ru.nl/science/analyticalchemistry/research/data-
analytical-chemistry/
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